Biotechnologies Llc Argyll, 10% Owner at IMMUNOSYN CORP (IMYN), sold 400,000 shares at $5.00 ($2.0M) on 2008-03-13, disclosed to the SEC on 2008-03-20.
Open-market sale of $2.0M IMYN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| IMYN | SELL | 2007-10-22 | $861K | — | Filing → |
| IMYN | SELL | 2007-10-16 | $1.7M | — | Filing → |
| PrivateIMMUNOSYN CORP | SELL | 2007-09-04 | $80.0M | — | Filing → |